Intersex

Current Opinion in Urology

Volumn 6, Issue 6, 1996, Pages 320-326

  Wiener, John S ^a   Gonzales Jr , Edmond T ^b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c Texas Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FETUS ECHOGRAPHY; FOLLOW UP; GONADAL DYSGENESIS; HERMAPHRODITISM; HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PSEUDOHERMAPHRODITISM; REVIEW; SELF CONCEPT; SEX DIFFERENTIATION; SEXUAL FUNCTION; SURGICAL TECHNIQUE; TRUE HERMAPHRODITISM;

EID: 0029908379     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199611000-00007     Document Type: Review

References (78)

1. Wiener JS, Marcelli M, Lamb DJ: Molecular mechanisms of sexual differentiation. World J Urol 1996, (in press). All aspects of male sexual differentiation are covered in this review. The role of more than 24 genes located on over 16 different chromosomes are detailed in the sexual differentiation pathway.
2. Gubbay J, Collignon J, Koopman P, Capel B, Economou A, Munsterberg A, Vivian N, Goodfellow P, Lovell-Badge R: A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature 1990, 346:245-250.
3. Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf AM, Lovell-Badge R, Goodfellow PN: A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 1990, 346:240-244.
4. Lopez M, Torres L, Mendez JP, Cervantes A, Alfaro G, Perez-Palacios G, Erickson RP, Kofman-Alfaro S: SPY alone can induce normal male sexual differentiation. Am J Med Genet 1995, 55:356-358.
5. Hawkins JR, Taylor A, Berta P, Levilliers J, Van der Auwera B, Goodfellow PN: Mutational analysis of SRY: nonsense and missense mutations in XY sex reversal. Hum Genet 1992, 88:471-474.
6. Jager RJ, Anvret M, Hall K, Scherer G: A human XY female with a frame shift mutation in the candidate testis-determining gene SRY Nature 1990, 348:452-454.
7. Harley VR, Goodfellow PN: The biochemical role of SRY in sex determination. Mol Reprod Dev 1994, 39:184-193.
8. Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA, Stevanovic M, Weissenbach J, Mansour S, Young ID, Goodfellow P, et al: Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994, 372:525-529.
9. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelii FD, Keutel J, Hustert E, et al.: Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene Sox9. Cell 1994, 79:1111-1120.
10. Bardoni B, Zanaria E, Guioli S, Floridia G, Worley KC, Tonini G, Ferrante E, Chiumello G, McCabe ERB, Fraccaro M, et al.: A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet 1994, 7:497-501.
11. Moore KL: The Developing Human: Clinically Oriented Embryology. Philadelphia: W.B. Saunders, 1982:271-293.
12. Wilson JD, Griffin JD, Russell DW: Steroid 5-alpha reductase 2 deficiency. Endocr Rev 1993, 14:577-593.
13. Smith DP, Felker RE, Noe HN, Emerson DS, Mercer B: Prenatal diagnosis of genital anomalies. Urology 1996, 47:114-117. Five cases of prenatal diagnosis of genital malformation are reported in this review. The technical aspects of prenatal sonography are discussed.
14. Bronshtein M, Riechler A, Zimmer EZ: Prenatal sonographic signs of possible fetal genital anomalies. Prenal Diagn 1995, 15:215-219.
15. Mandell J, Bromley B, Peters CA, Benacerraf BR: Prenatal sonographic detection of genital malformations. J Urol 1995, 153:1994-1996. The findings of 17 fetuses who were diagnosed prenatally with intersex and other genital anomalies are covered. The author's experience highlights the pitfalls and strengths of prenatal sonography.
16. Lumbroso S, Lobaccaro JM, Belon C, Amram S, Bachelard B, Garandeau P, Sultan C: Molecular prenatal exclusion of familial partial androgen insensitivity (Reifenstein syndrome). Eur J Endocrinol 1994, 130:327-332.
17. Lobaccaro JM, Belon C, Lumbroso S, Olewniczack G, Carre-Pigeon F, Job JC, Chaussain JL, Toublanc JE, Sultan C: Molecular prenatal diagnosis of partial androgen insensitivity syndrome based on Hind III polymorphism of the androgen receptor gene. Clin Endocrinol 1994, 40:297-302.
18. Mercado AB, Wilson RC, Cheng KC, Wei JQ, New MI: Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1995, 80:2014-2020. Over the past 9 years, the authors have diagnosed CAH prenatally in 239 pregnancies. Prenatal treatment with dexamethasone in 13 patients reduced vinlization.
19. Perrotti M, Mandell J, Mandell VS: Ethical issues of diagnosis in utero. Br J Urol 1995, 76(suppl 2):79-83. An overview of the ethical issues related to the prenatal diagnosis of genitourinary disorders is presented.
20. Blyth B, Churchill BM: Intersex. In Adult and Pediatric Urology, 3rd edn. Edited by Gillenwater J, Grayhack JT, Howard S, Duckett J. St. Louis: Mosby Year Book: 1996:2591-2621. This chapter is an encyclopedic review of all details of intersex. It is an excellent updated manuscript with 99 references.
21. Federman DD, Donahoe PK: Ambiguous genitalia - etiology, diagnosis, and therapy. Adv Endocrinol Metab 1995, 6:91-116. This concise review article offers a logical approach to the many complexities of intersex. Detailed surgical descriptions are included as well.
22. Grant DB: Ethical issues in children with ambiguous genitalia. Br J Urol 1995, 76(suppl 2):75-78. This thoughtful manuscript thoroughly covers the often difficult issues in treating intersex patients. No issue is more challenging than that of sex reassignment.
23. Mark HF, Meyers-Seifer CH, Seifer DB, Demoranville BM, Jackson IM: Assessment of sex chromosome composition using fluorescent in situ hybridization as an adjunct to GTG-banding. Ann Clin Lab Sci 1995, 25:402-408.
24. Gustafson ML, Lee MM, Asmundson L, MacLaughlin DT, Donahoe PK: Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities. J Pediatr Surg 1993, 28:439-444.
25. Davenport M, Brain C, Vandenberg C, Zappala S, Duffy P, Ransley PG, Grant D: The use of the hCG stimulation test in the endocrine evaluation of cryptorchidism. Br J Urol 1995, 76:790-794. Testosterone levels were measured before and after stimulation with human ch2orionic gonadotropin in 31 boys with at least one non-palpable testis. A twofold increase in testosterone had a positive predictive value of 89% and a negative predictive value of 100%.
26. Josso N, Legeai L, Forest MG, Chaussain JL, Brauner R: An enzyme-linked immunoassay for anti-Müllerian hormone: a new tool for the evaluation of testicular function in infants and children. J Clin Endocrinol Metab 1990, 70:23-27.
27. Rey R, Mebarki F, Forest MG, Mowszowicz I, Cate RL, Morel Y, Chaussain JL, Josso N: Anti-Müllerian hormone in children with androgen insensitivity. J Clin Endocrinol Metab 1994, 79:960-964.
28. Josso N: Pediatric applications of anti-Müllerian hormone research. Horm Res 1995, 43:243-248. All salient data pertaining to the use of MIS (anti-Müllerian hormone) in diagnosis and management of intersex patients is reviewed. This is the most up-to-date review of the subject.
29. Josso N, Lamarre I, Picard JY, Berta P, Davies N, Morichon N, Peschanski M, Jeny R; Anti-Müllerian hormone in early human development Early Hum Dev 1993, 33:91-99.
30. Wright NB, Smith C, Rickwood AMK, Carty HML: Imaging children with ambiguous genitalia and intersex states. Clin Radiol 1995, 50:823-829. This state-of-the-art article reviews the use of modern radiologic techniques to diagnose and manage intersex. Ultrasound, fluoroscopy, and MRI are most commonly used, and the authors present data relating to the accuracy of each technique.
31. Kutteh WH, Santos-Ramos R, Ermel LD: Accuracy of ultrasonic detection of the uterus in normal newborn infants: implications for infants with ambiguous genitalia. Ultrasound Obstet Gynecol 1995, 5:109-113.
32. Cohen HL, Shapiro MA, Mandel FS, Shapiro ML: Normal ovaries in neonates and infants: a sonographic study of 77 patients 1 day to 24 months old. AJR Am J Roentgenol 1993, 160:583-586.
33. Secaf E, Hricak H, Gooding CA, Ho VW, Gorczyca DP, Ringertz H, Conte FA, Kogan BA, Grumbach MM: Role of MRI in the evaluation of ambiguous genitalia. Pediatr Radiol 1994, 24:231-235.
34. Yu TJ, Shu K, Kung FT, Eng HL, Chen HY: Use of laparoscopy in intersex patients. J Urol 1995, 154:1193-1196. Successful surgical diagnostic and extripative laparoscopy was performed in four male pseudohermaphrodites and two patients with mixed gonadal dysgenesis.
35. Batzer FR, Nelson JR, Corson SL, Gocial B: Laparoscopic approach to definitive treatment of androgen insensitivity syndrome: a case report J Reprod Med 1994, 39:541-543.
36. Poppas DP, Lemack GE, Mininberg DT: Laparoscopic orchiopexy: clinical experience and description of technique. J Urol 1996, 155:708-711. The authors present a series of 13 laparoscopic orchidopexies in 11 patients with intra-abdominal testes. The early outcome at 3.5 months appears excellent.
37. Miller WL: Molecular biology of steroid hormone synthesis. Endocr Rev 1988, 9:295-318.
38. Donahoe PK, Gustafson ML: Early one-stage surgical reconstruction of the extremely high vagina in patients with congenital adrenal hyperplasia. J Pediatr Surg 1994, 29:352-358.
39. Hendren WH, Atala A: Repair of the high vagina in girls with severe masculinized anatomy from the adrenogenital syndrome. J Pediatr Surg 1995, 30:91-94.
40. Lee CK, Hanna MK, Brock WA, Packer M, Kaplan G: Complete virilization in 46,XX females with congenital adrenal hyperplasia: a series of 4 cases [Abstract]. J Urol 1996, 155:390A. Adrenogenital syndrome may present as phenotypic males with an empty scrotum. Because of normal female internal genitalia and potential fertility, the authors try to perform sex reassignment surgery in the neonatal period.
41. de Jong TP, Boemers TM: Neonatal management of female intersex by clitorovaginoplasty. J Urol 1995, 154:830-832. A series of five neonates with CAH successfully underwent clitoral reduction and vaginoplasty in the first month of life. There have been no complications in the short follow-up period of 3 years.
42. Gearhart JP, Burnett A, Owen JH: Measurement of pudendal evoked potentials during feminizing genitoplasty: technique and applications. J Urol 1995, 153:486-487.
43. Powell DM, Newman KD, Randolph J: A proposed classification of vaginal anomalies and their surgical correction. J Pediatr Surg 1995, 30:271-276.
44. Hojsgaard A, Villadsen I: Mclndoe procedure for congenital vaginal agenesis: complications and results. Br J Plast Surg 1995, 48:97-102.
45. Hitchcock RJI, Malone PS: Colovaginoplasty in infants and children. Br J Urol 1994, 73:196-199.
46. Beheshti M, Hardy BE, Churchill BM, Daneman D: Gender assignment in male pseudohermaphrodite children. Urology 1983, 22:603-607.
47. Smith DP, Rickman C, Jerkins GR: Ultrasound evaluation of normal penile (corporal) length in children. J Urol 1995, 154:822-824.
48. Perovic S: Phalloplasty in children and adolescents using the extended pedicle island groin flap. J Urol 1995, 154:848-853. This technique of phallic construction uses a pedicled groin flap based on the superficial iliac and epigastric vessels and is performed at the age of 10-14 years. The author claims it is simpler and faster than free grafts with a lower complication rate and no visible scar at the donor site. Its disadvantages included poor sensation and questionable rigidity.
49. Byun JS, Cho BC, Baik BS: Results of one-stage penile reconstruction using an innervated radial osteocutaneous flap. J Reconstr Microsurg 1994, 10:321-331.
50. Gilbert DA, Jordan GH, Devine CJ, Winslow BH, Schlossberg SM: Phallic construction in prepubertal and adolescent boys. J Urol 1993, 149:1521-1526.
51. Kristic Z, Perovic S, Radmanovic S, Necic S, Smoljanic Z, Jevtic P: Surgical treatment of intersex disorders. J Pediatr Surg 1995, 30:1273-1281. This encompassing review of experience with 84 intersex patients highlights the issues of gender assignment. The outcome data justifies their belief that most intersex children should be assigned female gender.
52. Taha SA: Male pseudohermaphrodism: factors determining the gender of rearing in Saudi Arabia. Urology 1994, 43:370-374.
53. Marcelli M, Tilley WD, Zoppi S, Griffin JE, Wilson JD, McPhaul MJ: Molecular basis of androgen resistance. J Endocrinol Invest 1992, 15:149-159.
54. Quigley CA, DeBellis A, Marschke KB, El-Awady MK, Wilson EM, French FS: Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995, 16:271-321. This comprehensive review of the androgen receptor and its alterations covers all aspects of the biology of androgen insensitivity.
55. Wiener JS, Teague JL, Roth DR, Gonzales ET, Lamb DJ: Molecular biology and function of the androgen receptor in genital development J Urol 1996, (in press). This review covers the role of androgen receptor in male genital development, as well as the molecular biology of androgen insensitivity. The section on management of patients with androgen insensitivity is particularly useful to clinicians.
56. Allera A, Herbst MA, Griffin JE, Wilson JD, Schweikert HU, McPhaul MJ : Mutations of the androgen receptor coding sequence are infrequent in patients with isolated hypospadias. J Clin Endocrinol Metab 1995, 80:2697-2699. In a series of nine boys with isolated hypospadias, one was found to contain a mutation in exon 2 of the androgen receptor. He had perineal hypospadias and a positive family history of hypospadias.
57. Sutherland RW, Wiener JS, Hicks JP, Marcelli M, Gonzales ET, Roth DR, Lamb DJ: Androgen receptor gene mutations are rarely associated with isolated hypospadias. J Urol 1996, 156:228-231. An androgen receptor gene mutation was found in one of 40 boys with various degrees of isolated hypospadias. This is the first known report of an androgen receptor gene mutation in association with distal penile shaft hypospadias.
58. Andersson S, Geissler WM, Wu L, Davis DL, Grumbach MM, New MI, Schwarz HP, Blethen SL, Mendonca BB, Bloise W, et al: Molecular genetics and pathophysiology of 17-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 1996, 81:130-136. This detailed study associated mutations of this androgenic enzyme with familial cases of male pseudohermaphroditism.
59. Mebarki F, Sanchez R, Rheaume E, Laflamme N, Simard J, Forest MG, Bey-Omar F, David M, Labrie R, Morel Y: Non-salt losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene. J Clin Endocrinol Metab 1995, 80:2127-2134.
60. Laue L, Wu SM, Kudo M, Hsueh AJ, Cutler GB, Griffin JE, Wilson JD, Brain C, Berry AC, Grant DB, et al.: A non-sense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet 1995, 4:1429-1433.
61. Wilson JD, Griffin JE, Russell DW: Steroid 5α-reductase in deficiency. Endocr Rev 1993, 14:577-593.
62. Imperato-McGinley J, Gautier T, Richardo M, Shackleton C: The diagnosis of 5α-reductase deficiency in infancy. J Clin Endocrinol Metab 1986, 63:1313-1318.
63. Lee MM, Donahoe PK: Müllerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 1993, 14:152-164.
64. Imbeaud S, Carre-Eusebe D, Rey R, Belville C, Josso N, Picard JY: Molecular genetics of the persistent mullerian duct syndrome: a study of 19 families. Hum Mol Genet 1994, 3:125-131.
65. di Clemente N, Wilson C, Faure E, Boussin L, Carmillo P, Tizard R, Picard JY, Vigier B, Josso N, Cate R: Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol Cell Endocrinol 1994, 8:1006-1020.
66. Imbeaud S, Faure E, Lamarre I, Mattei MG, di Clemente N, Tizard R, Carre-Eusebe D, Belville C, Tragethon L, Tonkin C, et al.: Insensitivity to anti-Müllerian hormone due to a mutation in the human anti-Mullerian hormone receptor. Nat Genet 1995, 11:382-388. The gene encoding the MIS receptor located on chromosome 12 was found to be mutated in a patient with MIS-positive PMDS.
67. Verp MS. Simpson JL: Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet 1987, 25:191-218.
68. Loeff DS, Imbeaud S, Reyes HM, Meller JL, Rosenthal IM: Surgical and genetic aspects of persistent Müllerian duct syndrome. J Pediatr Surg 1994, 29:61-65.
69. Imbeaud S, Rey R, Berta P, Chaussain JL, Wit JM, Lustig RH, De Vroede MA, Picard JY, Josso N: Testicular degeneration in three patients with the persistent Müllerian duct syndrome. Eur J Pediatr 1995, 154:187-190.
70. Krob G, Braun A, Kuhnle U: True hermaphroditism: geographical distribution, clinical findings, chromosomes, and gonadal histology. Eur J Pediatr 1994, 153:2-10.
71. Kropp BP, Keating MA, Moshang T, Duckett JW: True hermaphroditism and normal male genitalia: an unusual presentation. Urology 1995, 46:736-739.
72. Aaronson IA: True hermaphroditism. a review of 41 cases with observations on testicular histology and function. Br J Urol 1985, 57:775-779.
73. Luks FI, Hansbrough F, Klotz DH, Kottmeier PK, Tolete-Velcek F: Early gender assignment in true hermaphroditism. J Pediatr Surg 1988, 23:1122-1126.
74. Hadjiathanasiou CG, Brauner R, Lortat-Jacob S, Nivot S, Jaubert F, Fellous M, Nihoul-Fekete C, Rappaport R: True hermaphroditism: genetic variants and clinical management J Pediatr 1994, 125:738-744.
75. Donahoe PK, Crawford JD. Hendren WH: Mixed gonadal dysgenesis, pathogenesis, and management. J Pediatr Surg 1979, 14:287-300.
76. Borer JG, Nitti VW, Glassberg KI: Mixed gonadal dysgenesis and dysgenetic male pseudohermaphroditism. J Urol 1995, 153:1267-1273.
77. Muller J, Skakkebaek NE, Ritzen M, Ploen L, Petersen KE: Carcinomain-situ of the testis in children with 45,X/46,XY gonadal dysgenesis. J Pediatr 1985, 106:431-435.
78. Giwercman A, von der Maase H, Skakkebaek NE: Epidemiological and clinical aspects of carcinoma in situ of the testis. Eur Urol 1993, 23:104-110.